Problems of monitoring malignant neoplasms of the central nervous system in the Siberian Federal District and ways to solve them

Zhuikova L.D.

Cancer Research Institute — Tomsk National Research Medical Center Russian Academy of Sciences

ORCID: 0000-0003-3536-8473

Choynzonov E.L.

Cancer Research Institute — Tomsk National Research Medical Center Russian Academy of Sciences;
Siberian State Medical University

ORCID: 0000-0002-3651-0665

Ananina O.A.

Cancer Research Institute — Tomsk National Research Medical Center Russian Academy of Sciences

ORCID: 0000-0001-8002-3189

Kononova G.A.

Cancer Research Institute — Tomsk National Research Medical Center Russian Academy of Sciences

ORCID: 0000-0001-6010-6462

Pikalova L.V.

Cancer Research Institute — Tomsk National Research Medical Center Russian Academy of Sciences

ORCID: 0000-0003-1453-2254

Ryabova A.I.

Cancer Research Institute — Tomsk National Research Medical Center Russian Academy of Sciences

ORCID: 0000-0002-7171-8728

Zhuikova A.S.

Siberian State Medical University

ORCID: 0009-0006-7784-9442

Problems of monitoring malignant neoplasms of the central nervous system in the Siberian Federal District and ways to solve them

Authors:

Zhuikova L.D., Choynzonov E.L., Ananina O.A., Kononova G.A., Pikalova L.V., Ryabova A.I., Zhuikova A.S.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2024;88(5): 14‑22

DOI: 10.17116/neiro20248805114

Downloaded: 24

Download PDF (EN)

Contact the author

Table of contents

To cite this article:

Zhuikova LD, Choynzonov EL, Ananina OA, Kononova GA, Pikalova LV, Ryabova AI, Zhuikova AS. Problems of monitoring malignant neoplasms of the central nervous system in the Siberian Federal District and ways to solve them. Burdenko's Journal of Neurosurgery. 2024;88(5):14‑22. (In Russ., In Engl.)
https://doi.org/10.17116/neiro20248805114

Close metadata

BACKGROUND

Incidence and recording of neuro-oncological tumors comprise an important problem in the world and In Russia including the Siberian federal district.

OBJECTIVE

To analyze the incidence of malignant tumors of the central nervous system (CNS) (C70-72) in the Siberian federal district and appropriate constituent territories.

MATERIAL AND METHODS

Analysis of standardized indicators was based on form No. 7 “Information on malignant neoplasms” for the period 2013-2022, population and male-to-female ratio in the Siberian federal district.

RESULTS

The number of patients with CNS tumors increases in the Siberian federal district while relative rates of CNS cancer incidence are stable (men 5.2±0.2%, women 3.8±0.2%). The peak incidence has shifted from the age of 65-69 years to older category (75-79 years). Mean age of patients increased by 4.6 years (53.8±1.9 years in 2022) for men and 5.5 years (58.3±1.7 years in 2022) for women (p<0.001). We developed the algorithm for therapeutic and diagnostic care in patients with CNS tumors to solve permanent organizational problems in the Tomsk region. A specialized neuro-oncological registry based on territorial cancer registry was used.

CONCLUSION

Development and implementation of neuro-oncological registry programs for all tumors of the central nervous system will be valuable to assess oncological epidemiological situation. Moreover, we can expect earlier diagnosis and timely specialized treatment of such patients.

Keywords:

morbidity

routing

neuro-oncology registry

malignant neoplasms of the central nervous system

Siberian federal district

Authors:

Zhuikova L.D.

Cancer Research Institute — Tomsk National Research Medical Center Russian Academy of Sciences

ORCID: 0000-0003-3536-8473

Choynzonov E.L.

Cancer Research Institute — Tomsk National Research Medical Center Russian Academy of Sciences;
Siberian State Medical University

ORCID: 0000-0002-3651-0665

Ananina O.A.

Cancer Research Institute — Tomsk National Research Medical Center Russian Academy of Sciences

ORCID: 0000-0001-8002-3189

Kononova G.A.

Cancer Research Institute — Tomsk National Research Medical Center Russian Academy of Sciences

ORCID: 0000-0001-6010-6462

Pikalova L.V.

Cancer Research Institute — Tomsk National Research Medical Center Russian Academy of Sciences

ORCID: 0000-0003-1453-2254

Ryabova A.I.

Cancer Research Institute — Tomsk National Research Medical Center Russian Academy of Sciences

ORCID: 0000-0002-7171-8728

Zhuikova A.S.

Siberian State Medical University

ORCID: 0009-0006-7784-9442

Received:

21.03.2024

Accepted:

21.06.2024

List of references:

Kobiakov GL, Absaliamova OV, Poddubskiy AA, Lodygina KS, Kobyakova EA. The 2016 WHO classification of primary central nervous system tumors: a clinician’s view. Burdenko’s Journal of Neurosurgery. 2018;82(3): 88-96. (In Russ.). https://doi.org/10.17116/neiro201882388
Zhuykova LD, Choynzonov EL, Ananina OA, Pikalova LV, Odintsova IN, Kononova GA. Incidence of malignant brain and other central nervous system tumors (C70—C72) in Siberia and the Russian Far East. Head and Neck Tumors. 2021;11(4):64-72. (In Russ.). https://doi.org/10.17650/2222-1468-2021-11-4-64-72
Zhetpisbaev BB, Doskaliev AZh, Solodovnikov MP, Kasymova AB, Tursynov NI, Akshulakov SK. Molecular genetic studies of tumors of the central nervous system. Neurosurgery and neurology of Kazakhstan. 2020;4(61):42-50. (In Russ.). https://doi.org/10.53498/24094498_2020_4_42
Ryabova AI, Novikov VA, Gribova OV, Startseva ZhA, Grigoriev EG, Glushchenko SA, Ponomaryova AA, Sirkashev VA. The value of prognostic factors for glioblastoma treated with concurrent thermochemoradiotherapy. Siberian Journal of Oncology. 2018;17(5):27-36. (In Russ.). https://doi.org/10.21294/1814-4861-2018-17-5-27-36
Kobyakov GL, Smolin AV, Bekyashev AKh, Absalyamova OV, Kobyakova EA, Poddubskiy AA, Inozemtseva MV. Treatment of recurrent glioblastoma: is there any success? Tumors of the Head and Neck. 2014;3:12-21. (In Russ.).
Ostrom Q, Kruchko C, Neff C, Firth A, Sherman R. The Central Brain Tumor Registry of the United States Histopathological Grouping Scheme Provides Clinically Relevant Brain and Other Central Nervous System Categories for Cancer Registry Data. Journal of Registry Management. 2022;49(4):139-152.
Shonus DKh, Shcherbenko OI. Medulloblastoma in children. Clinical manifestations, diagnostics, treatment, unsolved problems (Literature review). Vestnik nevrologii, psikhiatrii i nejrokhirurgii. 2013;9:22-55. (In Russ.).
Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries [Internet]. Accessed March 04, 2024. https://gco.iarc.fr
Malignant neoplasms In Russia in 2013 (incidence and mortality). Kaprin AD, Starinsky VV, Petrov GV, eds. M.: P.A. Herzen Moscow Oncology Research Institute, Branch of the National Medical Research Center of Radiology of the Ministry of Health of the Russian Federation; 2015. (In Russ.).
Malignant neoplasms In Russia in 2021 (incidence and mortality). Kaprin AD, Starinsky VV, Shakhzadova AO, eds. M.: P.A. Herzen Moscow Oncology Research Institute, Branch of the National Medical Research Center of Radiology of the Ministry of Health of the Russian Federation; 2022. (In Russ.).
https://rosstat.gov.ru/compendium/document/13284 https://rosstat.gov.ru/compendium/document/13284
Goldin VD, Pisareva LF, Ananina OA, Odintsova IN, Boyarkina AP. Reg. certificate for the computer program “ONKOSTAT” (“Oncological statistics”). Application No. 2014611115 dated February 17, 2014, registration No. 2014616130 dated June 11, 2014 in Rospatent FGU FIPS. (In Russ.).
Ryabova AI, Lyalyuiko OA, Ananina OA, Pikalova LV, Novikov VA, Syrkashev VA, Muzenik OA, Vtorushin SV, Choynzonov EL. Characteristics of patients with central nervous system primary cancers in the Tomsk region. Profilakticheskaya Meditsina. 2024;27(2):44-50. (In Russ.). https://doi.org/10.17116/profmed20242702144
Siegel RL, Miller KD, Fuchs H, Jemal A. Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians. 2021;71:7-33. https://doi.org/10.3322/caac.21654
Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020. Neuro-Oncology. 2023;25(12 Suppl 2):iv1-iv99. https://doi.org/10.1093/neuonc/noad149
Krylov VV, Evzikov GYu, Kobyakov GL. Morphogenetic characteristics of glial tumors in adults per the WHO classifications of 2007, 2016, 2021. Changes in the classifications and their significance for clinical practice. Russian Journal of Neurosurgery. 2023;25(3):135-48. (In Russ.). https://doi.org/10.17650/1683-3295-2023-25-3-135-148
Pan’shin GA, Izmailov TR, Vazhinskaya NS. Current state of the issue on the problem of treatment of malignant gliomas of the brainstem (brief review of the literature). Bulletin of the Scientific Russian Center for X-Ray Radiology. 2021;21(1):12-33. (In Russ.).
WHO Classification of Tumours Editorial Board. Central nervous system tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2021. (WHO classification of tumours series, 5th edn.; vol. 6). Accessed March 04, 2024. https://tumorclassification.iarc.who.int/chapters/45

Close metadata